In a database of RCTs of women given hormone therapy or placebo and followed for at least six months—a total of 19 trials with more than 40,000 women—women who started hormone therapy less than ten years after menopause had fewer deaths from cardiovascular causes and lower rates of coronary heart disease than women on placebo or no treatment.